• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

结直肠癌异时性转移:何人、何事、何时及如何应对。

Metachronous colorectal cancer metastasis: Who, what, when and what to do about it.

机构信息

School of Biomedical Sciences, The University of Western Australia, Perth, Western Australia, Australia.

Colorectal Cancer Unit, St John of God Subiaco Hospital, Perth, Western Australia, Australia.

出版信息

J Surg Oncol. 2024 Jan;129(1):71-77. doi: 10.1002/jso.27400. Epub 2023 Jul 17.

DOI:10.1002/jso.27400
PMID:37458102
Abstract

Metachronous colorectal cancer (CRC) metastasis occurs due to micrometastatic disease, in up to 23% of patients who have undergone curative-intent treatment. Metachronous metastasis tends to occur within 2 years of initial treatment. Diagnosis relies on posttreatment surveillance strategies. Care for patients with metachronous CRC metastasis is complex and requires careful multidisciplinary consideration. Those with isolated and technically resectable diseases are recommended to undergo metastasectomy with adjunct chemotherapy, however, survival, even after curative-intent resection, is poor.

摘要

异时性结直肠癌(CRC)转移是由于微转移疾病引起的,在接受根治性治疗的患者中,高达 23%的患者会发生这种情况。异时性转移往往发生在初始治疗后 2 年内。诊断依赖于治疗后的监测策略。对异时性 CRC 转移患者的治疗较为复杂,需要仔细的多学科考虑。对于那些孤立的和技术上可切除的疾病,建议进行转移瘤切除术联合辅助化疗,但即使进行了根治性切除,生存情况仍较差。

相似文献

1
Metachronous colorectal cancer metastasis: Who, what, when and what to do about it.结直肠癌异时性转移:何人、何事、何时及如何应对。
J Surg Oncol. 2024 Jan;129(1):71-77. doi: 10.1002/jso.27400. Epub 2023 Jul 17.
2
Synchronous polyps predict metachronous colorectal lesions after curative resection of colorectal cancer.同步性息肉可预测结直肠癌根治性切除术后的异时性结直肠病变。
Acta Chir Belg. 2016 Aug;116(4):225-230. doi: 10.1080/00015458.2016.1171075. Epub 2016 Jun 21.
3
[Impact of time of occurrence of liver metastases (synchronous vs. metachronous) on early postoperative outcome and long-term survival of colorectal cancer patients].[肝转移发生时间(同时性与异时性)对结直肠癌患者术后早期结局及长期生存的影响]
Zentralbl Chir. 2014 Apr;139(2):220-5. doi: 10.1055/s-0032-1328568. Epub 2013 Jul 11.
4
Synchronous and metachronous colorectal cancers: distinct disease entities or different disease courses?同时性和异时性结直肠癌:不同的疾病实体还是不同的病程?
Hepatogastroenterology. 2015 Mar-Apr;62(138):286-90.
5
Incidence and risk factors of metachronous colorectal neoplasm after curative resection of colorectal cancer in Korean patients.韩国患者结直肠癌根治术后异时性结直肠肿瘤的发生率及相关危险因素分析。
J Dig Dis. 2014 Jul;15(7):367-76. doi: 10.1111/1751-2980.12154.
6
Impact of Synchronous Versus Metachronous Onset of Colorectal Peritoneal Metastases on Survival Outcomes After Cytoreductive Surgery (CRS) with Hyperthermic Intraperitoneal Chemotherapy (HIPEC): A Multicenter, Retrospective, Observational Study.结直肠腹膜转移同步与异时发生对细胞减灭术(CRS)联合腹腔热灌注化疗(HIPEC)后生存结局的影响:一项多中心、回顾性、观察性研究。
Ann Surg Oncol. 2019 Jul;26(7):2210-2221. doi: 10.1245/s10434-019-07294-y. Epub 2019 Mar 15.
7
A preliminary analysis of combined liver resection with new chemotherapy for synchronous and metachronous colorectal liver metastasis.联合新化疗的肝切除术治疗结直肠癌肝转移的初步分析。
Asian J Surg. 2009 Oct;32(4):189-97. doi: 10.1016/S1015-9584(09)60394-8.
8
Risk factors for metachronous adenoma in the residual colon of patients undergoing curative surgery for colorectal cancer.接受结直肠癌根治性手术患者残留结肠中异时性腺瘤的危险因素。
Int J Colorectal Dis. 2017 Nov;32(11):1609-1616. doi: 10.1007/s00384-017-2881-x. Epub 2017 Aug 21.
9
Metachronous peritoneal carcinomatosis after curative treatment of colorectal cancer.结直肠癌根治性治疗后发生的异时性腹膜癌转移
Eur J Surg Oncol. 2014 Aug;40(8):963-9. doi: 10.1016/j.ejso.2013.10.001. Epub 2013 Oct 16.
10
Higher incidence of metachronous advanced neoplasia in patients with synchronous advanced neoplasia and left-sided colorectal resection for colorectal cancer.对于因结直肠癌而行左半结肠切除术且同时患有进展期肿瘤的患者,其发生异时性进展期肿瘤的几率更高。
Gastrointest Endosc. 2018 Aug;88(2):348-359.e1. doi: 10.1016/j.gie.2018.03.011. Epub 2018 Mar 21.

引用本文的文献

1
Exploring the Role of Cellular Interactions in the Colorectal Cancer Microenvironment.探索细胞间相互作用在结直肠癌微环境中的作用。
J Immunol Res. 2025 Apr 11;2025:4109934. doi: 10.1155/jimr/4109934. eCollection 2025.
2
Risk Factors for Death from Heart Disease in Elderly Colon Cancer Patients with Liver Metastasis.老年结肠癌肝转移患者心脏病死亡的危险因素
Asian Pac J Cancer Prev. 2024 Dec 1;25(12):4217-4221. doi: 10.31557/APJCP.2024.25.12.4217.
3
KRAS inhibitors may prevent colorectal cancer metachronous metastasis by suppressing TGF‑β mediated epithelial‑mesenchymal transition.
KRAS 抑制剂可能通过抑制 TGF-β 介导的上皮-间充质转化来预防结直肠癌的异时转移。
Mol Med Rep. 2025 Jan;31(1). doi: 10.3892/mmr.2024.13389. Epub 2024 Nov 14.